안전한 바카라 사이트 Invites earns CAP accreditation as Korea’s sole non-medical institution recognized by the College of American Pathologists

[by Yu, Suin] 안전한 바카라 사이트 Invites announced on May 20 that its current next-generation sequencing (NGS) and microarray-based testing services have been officially accredited by the College of American Pathologists (CAP).

The College of American Pathologists (CAP) is recognized as the world's largest academic society in the field and the most authoritative organization for clinical laboratory accreditation in pathology. Accordingly, CAP accreditation is widely regarded as a global standard and guideline for assessing clinical laboratory quality control.

The certification process entails a thorough on-site inspection conducted by the evaluation committee to rigorously assess whether all aspects of clinical testing, including performance, management, documentation, employee proficiency, facility conditions, equipment, safety protocols, and overall operational procedures, are maintained at the highest standards of quality and compliance.

안전한 바카라 사이트 Invites stated that the certification recognizes its next-generation sequencing and microarray clinical testing processes meet the highest global standards. With this achievement, the company has become the only non-medical institution in Korean to receive CAP accreditation.

“The CAP certification has enabled the company to offer world-class genome analysis services, establishing a solid foundation for expanding its testing portfolio by strengthening the external competitiveness of our genome analysis capabilities in both Korea and international markets,” expressed Oh Soo-yeon, CEO of 안전한 바카라 사이트 Invites.

On the other hand, the Invites ecosystem, centered around 안전한 바카라 사이트 Invites, is a healthcare consortium dedicated to implementing data-based personalized health management, disease management, and artificial intelligence (AI)-based disease prediction. By integrating core competencies across the group, the ecosystem is constructing a comprehensive value chain for customized precision healthcare, encompassing the entire cycle from data measurement and collection to analysis, integration, and commercialization.